Ocugen, Inc. (OCGN) income statement
OCGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.77+0.04 (+4.79%)
Close on Nov 20, 2026Market cap $260.40MP/E –Yield –
Ocugen, Inc. financial ratios
See a number that looks wrong?